# A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis

> **NCT01048866** · PHASE3 · COMPLETED · sponsor: **Reckitt Benckiser LLC** · enrollment: 198 (actual)

## Conditions studied

- Pharyngitis

## Interventions

- **DRUG:** placebo
- **DRUG:** flurbiprofen
- **DRUG:** acetaminophen 650mg

## Key facts

- **NCT ID:** NCT01048866
- **Lead sponsor:** Reckitt Benckiser LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2017-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01048866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01048866, "A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01048866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*